Mar. 11 at 6:09 AM
$SLS there have been an unusual amount of unconfirmed rumors, today.
$PFE
- SLS did terminate the entire direct commercialization team 2 years ago, pursuing partnerships and 'beyond'.
- We know the Ceo disclosed there have been interested Pharma's, large and small. We know he's been negotiating.
His quote at the time, he "would inform the public when he had SOMETHING CONCRETE". Exact quote.
- the CFO GC 8K both Employment Contract Revised accelerating Option Vesting upon COC.
CFO/GC's do all the internal Due Diligence work and essentially working themselves out of a Job.
- there have been no HR moves to add for a Go It alone Strategy, this far along. P3 P2B, be managerial malpractice.
- the lack of RSU's for CEO and GC
- 56 day quiet period
- No SLS009 Trial News --- very odd, as I've posted.
009 P2b Data was better than p1B data - worth
$4.9B
- Big Pharma's
$ABBV $BMY Rhhby KNOW GPs works, BAT FAILED, would be willing to pay close to Ceo;s max value. https://www.youtube.com/watch?v=GRyZBZ2vXG0
